Senti Biosciences, Inc. Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q1 2021 to Q1 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary: Senti Biosciences, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2021 to Q1 2024.
Senti Biosciences, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$11.7M, a 28.3% increase year-over-year.
Senti Biosciences, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$52.4M, a 50.1% decline from 2022.
Senti Biosciences, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$34.9M, a 0.75% decline from 2021.

Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)

Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q1 2024	-$11.7M	+$4.62M	+28.3%	Mar 31, 2024	10-Q	2024-05-09
Q1 2023	-$16.3M	-$6.25M	-62.1%	Mar 31, 2023	10-Q	2024-05-09
Q1 2022	-$10.1M	-$10.1M		Mar 31, 2022	10-Q	2023-05-09
Q2 2021	-$935K			Jun 30, 2021	10-Q/A	2021-12-10
Q1 2021	$0			Mar 31, 2021	10-Q	2022-05-16

* An asterisk sign (*) next to the value indicates that the value is likely invalid.